WithdrawnPhase 2
Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
Reason given: Funding has not been solidified for the initiation of the study.
Key facts
- Where
- New York, United StatesSee the site
- Phase
- Phase 2
Where in United States
- Weill Cornell Medical College of Cornell UniversityNew York, United StatesNo longer taking part
Trial details
- Who runs it
- Weill Medical College of Cornell University
- Trial code
- NCT04298541
- Record updated
- 31 August 2026
- Original description
The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.Read full original descriptionShow less
SSTR2-Targeted PET Imaging of Meningioma: Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.
Inclusion: Adult patients with clinically suspected meningioma; Patients planned for surgery - undergoing preoperative workup; No contraindications to either radiotracer.
Exclusion: Age less than 18 years; Inability to lay on the scanner table for the required period of time, e.g., due to bone pain or claustrophobia.